Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alyson Harty"'
Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
Autor:
Sweta Chekuri, Jillian Nickerson, Kian Bichoupan, Roberta Sefcik, Kamini Doobay, Sanders Chang, David DelBello, Alyson Harty, Douglas T Dieterich, Ponni V Perumalswami, Andrea D Branch
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159413 (2016)
BACKGROUND AND AIM:To investigate the impact of a sustained virological response (SVR) to hepatitis C virus (HCV) treatment on liver stiffness (LS). METHODS:LS, measured by transient elastography (FibroScan), demographic and laboratory data of patien
Externí odkaz:
https://doaj.org/article/0a72a6ee6ecc461ab52aa54b154a2777
Autor:
Arpan Patel, Ritu Agarwal, Ponni V. Perumalswami, Thomas D. Schiano, Nina Kogekar, Cynthia Cohen, Kamron Pourmand, Douglas T. Dieterich, Andre Pelham-Braithwaite, Eugenia Tsai, James Phillip Esteban, Alyson Harty
Publikováno v:
Journal of Pain and Symptom Management. 59:864-870
Background Despite significant morbidity and mortality among patients with decompensated cirrhosis, reported rates of advance directive (AD) completion and goals of care discussions (GCDs) between patients and providers are very low. We aimed to impr
Autor:
Julie C. Sung, Ciara Bosh, Brooke Wyatt, Mark Miller, Alyson Harty, David Del Bello, Sterling Knight, Douglas T. Dieterich, Ponni V. Perumalswami, Andrea D. Branch
Publikováno v:
Journal of Viral Hepatitis. 27:350-359
Autor:
Amreen Dinani, Brooke Wyatt, Mark W. Miller, Ning Ma, Maxence Vandromme, Li Li, Andrea D. Branch, Francina Collado, Chip A. Bowman, Jihae Jeon, Lismeiry Paulino, Ponni V. Perumalswami, Douglas T. Dieterich, Alyson Harty, Anna Mageras
Publikováno v:
Hepatology (Baltimore, Md.). 74(6)
BACKGROUND AND AIMS Although chronic HCV infection increases mortality, thousands of patients remain diagnosed-but-untreated (DBU). We aimed to (1) develop a DBU phenotyping algorithm, (2) use it to facilitate case finding and linkage to care, and (3
Autor:
Nancy Bach, Meena B. Bansal, Joseph A. Odin, Scott L. Friedman, David Del Bello, Jennifer Leong, Kian Bichoupan, Joshua Hartman, Douglas T. Dieterich, Michel Ng, Charissa Chang, Neeta Tandon, Sweta Chekuri, Lawrence U. Liu, Neal Patel, Thomas D. Schiano, Priya Grewal, Keith Sigel, Gene Y. Im, James F. Crismale, Ponni V. Perumalswami, Andrea D. Branch, Alyson Harty
Publikováno v:
World Journal of Virology
AIM To assess the real-world effectiveness and cost of simeprevir (SMV), and/or sofosbuvir (SOF)-based therapy for chronic hepatitis C virus (HCV) infection. METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin (RBV), SOF/
Autor:
Neal Patel, L. Ku, Andrea D. Branch, Viktoriya Khaitova, Thomas D. Schiano, Priya Grewal, Douglas T. Dieterich, Mark Woodward, Alyson Harty, R. Yalamanchili, Charissa Chang, Ponni V. Perumalswami, Lawrence U Liu, Kian Bichoupan, David Motamed
Publikováno v:
Journal of Viral Hepatitis. 23:667-676
To conduct surveillance and determine the safety profile of new hepatitis C virus treatments in real-world clinical practice. Hepatic decompensation and other serious adverse events were investigated in an observational cohort study of 511 patients t
Autor:
Kian Bichoupan, Donald Gardenier, Daniel S. Fierer, Michel Ng, Alyson Harty, Maria A. Sorbera, Agnes Cha, Calley Levine, Joseph A. Odin, Leonard Berkowitz, Neal Patel, Erin Doyle, Thomas D. Schiano, David Del Bello, Douglas T. Dieterich, Ponni V. Perumalswami, Andrea D. Branch
Publikováno v:
Clinical Infectious Diseases. 62:1497-1504
BACKGROUND Patients with hepatitis C virus (HCV) with or without human immunodeficiency virus (HIV) achieve high sustained virological response (SVR) rates on sofosbuvir (SOF)-containing regimens in clinical trials. Real world data on patients coinfe
Autor:
Andrea D. Branch, Brooke Wyatt, Anna Mageras, Maxence Vandromme, Alyson Harty, Mark W. Miller, Li Li, Joel T. Dudley, Ponni V. Perumalswami, Douglas T. Dieterich
Publikováno v:
Journal of Hepatology. 70:e502
Autor:
Douglas T. Dieterich, Rachana Yalamanchili, Michel Ng, Ritu Agarwal, Neal Patel, Donald Gardenier, Meena B. Bansal, Jawad Ahmad, Viktoriya Khaitova, Thomas D. Schiano, Priya Grewal, Lawrence Ku, Scott L. Friedman, Kian Bichoupan, Charissa Chang, Andrea D. Branch, Joseph A. Odin, Jennifer Leong, Gene Im, David Motamed, Leona Kim-Schluger, Ponni V. Perumalswami, Nancy Bach, Lawrence Liu, Alyson Harty
To determine the safety profile of new hepatitis C virus (HCV) treatments in liver transplant (LT) recipients with recurrent HCV infection.Forty-two patients were identified with recurrent HCV infection that underwent LT at least 12 mo prior to initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf0144802b32cae72b0e10137c38915
https://europepmc.org/articles/PMC4778007/
https://europepmc.org/articles/PMC4778007/
Publikováno v:
American Journal of Gastroenterology. 111:S1360